RepliCel Life Sciences Inc.

08/04/2022 | Press release | Distributed by Public on 08/04/2022 09:41

Independent Testing Performed by Innovacell Demonstrates the DermaPreciseTM Control Leads to Unparalleled Post-Injection Cell Survival and Viability Consistency - Form 6-K